That's crucial, due to the fact that the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (jeff brown investor prediction). But now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're created to do. This was an advancement practically nobody observed. But it's going to have profound ramifications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment chances in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech pick). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back possibly considerably before going greater - democratic republic. I've been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time. We were primarily informing readers. But that's not the big concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. social media. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of terrific private companies on the edge of hitting the general public markets And I've been dealing with a brand-new way for you to invest even before these companies go public.
This opportunity has been building over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the details. Go right here to book your area free of charge.
Emma Walsh here, managing editor of the Diary. Routine Diary readers understand that tech isn't our usual beat (artificial intelligence). And when it concerns tech investing, we leave it to the experts. Thankfully, we have a number of such experts in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing experts we understand (longtime readers). In fact, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing exponential growth and creating unbelievable chances for financiers. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. biotech stocks jeff brown. However in spite of what lots of readers might think, this is a trend that's just getting going. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (tech stock). Losing 2 months of manufacturing and sales truly affects the number of 5G devices are sold in the calendar year. When you consider all of that, offering 250 million systems is impressive. More notably, the delays brought on by the pandemic created a load of pent-up demand. And that demand is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown predictions for 2021. And that's not my only 5G prediction When I've talked about 5G in the past, I have actually explained its three different stages.
In Phase Two, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Phase 3, 5G services start to be provided (jeff brown top biotech 2020). That's when we start to see applications working on 5G networks. Think about things like enormous multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summer. This begins something of a virtuous cycle: The majority of people do not really care about the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In fact, 5G is going to open a suite of amazing applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities moving forward will be enormous. Stepping far from 5G, the next essential innovation I anticipate in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not operate properly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were actually only 3 companies running in this space. However things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating illness and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing extraordinary returns. This whole market is successfully a greenfield opportunity.
There's room for lots of companies to exist in this area. artificial intelligence. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things taking place at the merging of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software can accurately forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That's crucial since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been a trial-and-error procedure. However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but a number of drug treatments produced using this technology. This was among those advancements that practically nobody observed. However it's going to have profound implications for curing disease. And, obviously, there will be a lot of financial investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back perhaps significantly prior to going higher. I've been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin - jeff brown latest prediction. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. last year. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date as of February 2021, however we might not independently verify this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like capability to select winning technology stocks. He spent more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an excellent perspective on the market. He's constantly on the hunt for new chances, and he shares much of his best choices in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding track record as a stock-picker, and he successfully predicted a few of the greatest economic occasions of the past twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it best every time, but Jeff Brown's precise forecasts have earned him legions of dedicated followers. That states a lot about his capability. The Future Report is released by Brownstone Research, a popular financial research study publisher. Brownstone Research study provides a number of research study services with a wide range of expertises - jeff brown 1 biotech.
The company is also associated with Bonner & Partners, another well-respected research study publisher - first lady. On its website, Brownstone says its mission is to supply retail financiers with professional-grade research: "For too long, the very best financial investment research has not been offered to private investors. It has been normally scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. melania trump. The mission of Brownstone Research is to make that kind of exclusive research offered to any financiers wanting to acquire an edge in the markets. The objective is basic to provide special and lucrative financial investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the company's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you know even a little bit about the marketplace, you understand that he has a track record as a King Midas of sorts. artificial intelligence. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown thinks S.A.V. brownstone research. could be "the greatest pattern of the 2020s, and he's not alone. Take a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding two advanced innovations: synthetic intelligence and electrical cars and trucks. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing brief of the automotive industry's Holy Grail. As you know, electrical vehicles and self-driving car stocks have been substantial this year, but the Wall Street device has actually approved buzz without much tangible outcome. Despite a drastic increase in competition over the past couple of years, Brown still believes Musk has the finest opportunity of putting all of it together.
tech might be the magic string that connects everything together. S.A.V. represents Shared Autonomous Lorry, and it could be the future of transportation. Essentially, this technology would permit you to lease out your automobile as a self-governing, self-driving taxi when you're not utilizing it. You merely get out of the cars and truck and press a button on an app that informs the cars and truck to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the revenues. It sounds outrageous, but it could be closed than you think.